Back to search

Article

Linagliptin, when compared to placebo, improves CD34+ve Endothelial Progenitor Cells in Type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin, a randomized controlled trial.

2020-03-30

Abstract excerpt

<title>Abstract</title> <p>Introduction: Endothelial Progenitor cells (EPCs) has been shown to be dysfunctional in both Type 2 Diabetes and Chronic Kidney Disease (CKD) leading to poor regeneration of endothelium and renal perfusion. EPCs have been shown to be a robust cardiovascular disease (CVD) risk indicator. Cellular mechanisms of DPP4 inhibitors such as Linagliptin (LG) on CVD risk, in patients with Type 2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c197a5c1-df74-55e6-a0a9-84d8136375b6
DOI
10.21203/rs.3.rs-18330/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Linagliptin, when compared to placebo, improves CD34+ve Endothelial Progenitor Cells in Type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin, a randomized controlled trial.DOI 10.21203/rs.3.rs-18330/v1
Role of Canagliflozin on function of CD34+ endothelial progenitor cells (EPC) in patients with type 2 diabetesSemantic proximity
Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes.Semantic proximity
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.Semantic proximity
Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.Semantic proximity
Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stressSemantic proximity
Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.Semantic proximity
PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanismsSemantic proximity
Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.Semantic proximity
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes.Semantic proximity
Exenatide and renal outcomes in patients with type 2 diabetes and diabetic kidney disease: a multi-center, randomized, parallel studySemantic proximity
Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.Semantic proximity
Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.Semantic proximity
Select a neighboring publication to make it the new centre.